ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 1466

Altered Count of NK Cells and Non-Classical Monocyte Subpopulation in the Pre-Clinical Phase of Rheumatoid Arthritis

Klára Prajzlerová1, Olga Kryštůfková2, Petra Hánová1, Hana Hulejová3, Monika Gregová4, Karel Pavelka4, Jiri Vencovsky1, Ladislav Šenolt5 and Mária Filková1, 1Department of Rheumatology, First Faculty of Medicine, Charles University and Rheumatology Institute, Prague, Czech Republic, Prague, Czech Republic, 2Department of Rheumatology, First Faculty of Medicine, Charles University and Rheumatology Institute, Prague, Czech Republic, prague, Czech Republic, 3Rheumatology Institute, Prague, Czech Republic, Prague, Czech Republic, 4Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 5First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: ACPA, monocytes, natural killer (NK) cells, rheumatoid arthritis (RA) and risk

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Anti-citrullinated protein antibodies (ACPA) are detectable long before the manifestation of rheumatoid arthritis (RA). EULAR provided a clinical definition of individuals with arthralgia suspicious for progression to RA (clinically suspect arthralgia, CSA). The alteration of monocyte subpopulations in patients with established RA has been described. We aimed to evaluate possible predictive value of the monocyte and lymphocyte subpopulations in individuals in the preclinical phase of RA.

Methods:

Thirty-four individuals with arthralgia (mean age 45.11±12.6 years; 91% females) and 80 age and gender matched healthy controls (HC) were included. Leukocytes from peripheral blood were analysed by flow cytometry. Lymphocyte subpopulations were defined as CD19+CD3-, CD3+CD4+, CD3+CD8+ and CD16/56+CD3- (NK) cells, monocytes were segregated into classical (CD14+CD16-), intermediate (CD14+CD16+/++) and non-classical (CD14-/dimCD16++) subsets. Data were analysed using t-test and Spearman’s correlation and are expressed as median and interquartile range (IQR).

Results:

Out of 34 patients with arthralgia, 27 were ACPA+ and 17 met CSA definition (10 of them were ACPA+), with symptoms duration 36 months (IQR: 77.5), CRP 2.27 mg/L (IQR 3.35), DAS28 2.13 (IQR 1.32). As per definition, there was no clinical synovitis at baseline. Five individuals developed RA within 3-9 months of follow up.

Patients with arthralgia had higher %CD3+ (p=0.002) and %CD3+CD8+ (p=0.034) T cells and lower %NK (p=0.003) and absolute count of NK cells (p=0.002) compared to HC. This was confirmed in a subgroup of ACPA+ patients. The count of tender joints correlated positively with %CD3 (p=0.009; r=0.491) and %CD3CD8 (p=0.034; r=0.410) T cells and negatively with %NK cells (p=0.019; r=0.045). Moreover, individuals who developed RA during follow up, had higher baseline %CD3+ cells (p=0.046) with the trend for lower %NK cells (p=0.065). No differences were seen between patients meeting CSA definition and non-CSA individuals.

Expansion of intermediate (p=0.012) and non-classical (p=0.007) monocytes with reduction of classical monocytes (p=0.001) were demonstrated in all patients with arthralgia compared to HC. Importantly, ACPA+ patients had higher non-classical (p=0.041) and lower classical monocytes (p=0.022) than ACPA- patients. Similarly, ACPA+ patients had higher intermediate (p=0.006) or non-classical (p=0.012) and lower classical (p=0.004) monocytes compared to HC, while no differences were seen between ACPA- patients and HC.

Conclusion:

We demonstrate lower NK cells, expansion of intermediate and non-classical monocyte subpopulation in patients in the preclinical phase of RA, especially in ACPA+ individuals. Since this pattern has been described so far in patients with established RA, our data suggest their role even in early phases of RA development. These leukocyte subpopulations could be considered as prognostic biomarkers for further development of RA.

Acknowledgement: Projects AZV-17-32612A and MHCR 023728.


Disclosure: K. Prajzlerová, None; O. Kryštůfková, None; P. Hánová, None; H. Hulejová, None; M. Gregová, None; K. Pavelka, None; J. Vencovsky, None; L. Šenolt, None; M. Filková, None.

To cite this abstract in AMA style:

Prajzlerová K, Kryštůfková O, Hánová P, Hulejová H, Gregová M, Pavelka K, Vencovsky J, Šenolt L, Filková M. Altered Count of NK Cells and Non-Classical Monocyte Subpopulation in the Pre-Clinical Phase of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/altered-count-of-nk-cells-and-non-classical-monocyte-subpopulation-in-the-pre-clinical-phase-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2018

ACR Meeting Abstracts - https://acrabstracts.org/abstract/altered-count-of-nk-cells-and-non-classical-monocyte-subpopulation-in-the-pre-clinical-phase-of-rheumatoid-arthritis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology